"Drug makers would be especially unlikely to turn away from immunotherapy , where the promising science has set off a " gold rush mentality , " according to Mark Edwards of Bioscience Advisors , a company which tracks pharmaceutical licensing deals .The National Institutes of Health , the parent agency of the National Cancer Institute , currently has about 400 cooperative research agreements with companies , and licenses hundreds of patented inventions for    development .Kite executives and national health officials characterize their partnership as a model arrangement Kite executives and national health officials a system established by Congress three decades ago .